Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward Greeno

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Investigational New Drugs|March 7, 2018
Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studiesHerbert Hurwitz, Eric Van Cutsem, Johanna Bendell, et al.
World Journal of Gastroenterology|March 6, 2015
Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumorsJonathan R Strosberg, George A Fisher, Al B Benson, et al.
Pancreas|December 6, 2012
Systemic treatment in unresectable metastatic well-differentiated carcinoid tumors: consensus results from a modified delphi processJonathan R Strosberg, George A Fisher, Al B Benson, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Investigational New Drugs|March 7, 2018
Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studiesHerbert Hurwitz, Eric Van Cutsem, Johanna Bendell, et al.
World Journal of Gastroenterology|March 6, 2015
Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumorsJonathan R Strosberg, George A Fisher, Al B Benson, et al.
Pancreas|December 6, 2012
Systemic treatment in unresectable metastatic well-differentiated carcinoid tumors: consensus results from a modified delphi processJonathan R Strosberg, George A Fisher, Al B Benson, et al.
Pageof 2